Rifaximin Prevents Overt Hepatic Encephalopathy After TIPS

MONDAY, Feb. 1, 2021 -- For patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt (TIPS) placement, rifaximin used before and after the procedure is associated with a reduced risk for overt hepatic encephalopathy (HE),...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news